at 24 weeks, there were no statistically significant differences between the placebo group and any of the active-treatment groups for the change from baseline in testosterone, human chorionic gonadotropin (hcg)stimulated testosterone, free testosterone index, follicle-stimulating hormone (fsh), luteinizing hormone (lh), or sex hormone-binding globulin (shbg).